Antimicrobial peptides (AMP) form a first line of defense of the innate immune system and have a broad spectrum of microbicidal activity against a wide range of Gram-negative and Gram-positive bacteria, fungi, protozoa, and even enveloped viruses. Recently they became a matter of increasing interest because of their excellent potential in treating diseases which cannot be cured by conventional antibiotics due to antimicrobial resistance. AMPs either induce membrane damage that is a lethal event for target bacteria or bind to several targets in the cytoplasmic region of the bacteria. All the evidence indicates that the action of the AMPs does not involve stereospecific protein-receptor recognition, since the interactions of AMPs with their targets are generally considered to be nonspecific. Therefore, the character of AMP interaction with bacterial cell wall lipids, viral envelope, or native plasma cell membrane lipids largely determine their lytic potential. As part of our study, novel planar biomimetic membranes, both at air-water and solid-liquid interface will be developed. This will allow use of highly sensitive structural experimental techniques, which cannot be employed with vesicle systems nor with real cells. Furthermore, in addition to AMP we also plan to investigate membrane interactions of their synthetic peptoid mimics (ampetoids), which have an advantage of being protease-resistant, while showing high potency and selectivity as antimicrobial agents. In this highly interdisciplinary proposal we plan to use cutting edge synchrotron X-ray scattering techniques, which together with AFM and epifluorescence studies will yield near atomic resolution of peptide-lipid interaction. These data will be used to advance the understanding of AMP and ampetoids mode of action which can be used to develop rational design strategies for AMPs and antimicrobial peptide mimics to advance development of highly potent drugs that are effective even against multidrug resistant bacteria and viruses.
Specific aims of this project are: (1) Examine the modes of interaction of ampetoids and natural AMPs with lipid monolayers representing an outer leaflet of red blood cell membranes and surface layer of bacterial cell wall using synchrotron grazing incidence X-ray diffraction, X-ray reflectivity, epifluorescence microscopy, and AFM used in complementary manner. (2) Design novel fluid bilayer membranes at the air-water interface, use them to examine the interaction of AMPs and ampetoids with both leaflets of bilayer membrane. (3) Design novel cholesterol tethered bilayer lipid membranes (tBLM) with cytoskeleton component. Examine mechanism of AMPs and ampetoids interaction with these tBLMs and elucidate role of cytoskeleton in their interactions. The broader impact of the proposed research is to advance development of novel antibiotic and antiviral drugs that will be immune to bacterial and viral mutations. Antimicrobial peptides and their synthetic mimics have enormous potential with regard to bacterial resistance because they interact not only with specific membrane protein receptors, but also with the lipid matrix of cell membranes, whose lipid composition is highly unlikely to change as a result of bacterial mutation. Better understanding of antimicrobial peptides and peptoids mode of action on molecular level could enhance the design and development of potent alternatives to the conventional antibiotics and antiviral drugs used today.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI073892-03
Application #
7900574
Study Section
Biomaterials and Biointerfaces Study Section (BMBI)
Program Officer
Xu, Zuoyu
Project Start
2008-07-01
Project End
2012-06-30
Budget Start
2010-07-01
Budget End
2011-06-30
Support Year
3
Fiscal Year
2010
Total Cost
$286,677
Indirect Cost
Name
Illinois Institute of Technology
Department
Engineering (All Types)
Type
Schools of Engineering
DUNS #
042084434
City
Chicago
State
IL
Country
United States
Zip Code
60616
Andreev, Konstantin; Martynowycz, Michael W; Huang, Mia L et al. (2018) Hydrophobic interactions modulate antimicrobial peptoid selectivity towards anionic lipid membranes. Biochim Biophys Acta Biomembr 1860:1414-1423
Andreev, Konstantin; Martynowycz, Michael W; Ivankin, Andrey et al. (2016) Cyclization Improves Membrane Permeation by Antimicrobial Peptoids. Langmuir 32:12905-12913
Nobre, Thatyane M; Martynowycz, Michael W; Andreev, Konstantin et al. (2015) Modification of Salmonella Lipopolysaccharides Prevents the Outer Membrane Penetration of Novobiocin. Biophys J 109:2537-2545
Andreev, Konstantin; Bianchi, Christopher; Laursen, Jonas S et al. (2014) Guanidino groups greatly enhance the action of antimicrobial peptidomimetics against bacterial cytoplasmic membranes. Biochim Biophys Acta 1838:2492-2502
Ivankin, Andrey; Apellániz, Beatriz; Gidalevitz, David et al. (2012) Mechanism of membrane perturbation by the HIV-1 gp41 membrane-proximal external region and its modulation by cholesterol. Biochim Biophys Acta 1818:2521-8
Ivankin, Andrey; Kuzmenko, Ivan; Gidalevitz, David (2012) Cholesterol mediates membrane curvature during fusion events. Phys Rev Lett 108:238103
Apellaniz, Beatriz; Ivankin, Andrey; Nir, Shlomo et al. (2011) Membrane-proximal external HIV-1 gp41 motif adapted for destabilizing the highly rigid viral envelope. Biophys J 101:2426-35
Ivankin, Andrey; Livne, Liran; Mor, Amram et al. (2010) Role of the conformational rigidity in the design of biomimetic antimicrobial compounds. Angew Chem Int Ed Engl 49:8462-5
Neville, Frances; Ivankin, Andrey; Konovalov, Oleg et al. (2010) A comparative study on the interactions of SMAP-29 with lipid monolayers. Biochim Biophys Acta 1798:851-60
Ivankin, Andrey; Kuzmenko, Ivan; Gidalevitz, David (2010) Cholesterol-phospholipid interactions: new insights from surface x-ray scattering data. Phys Rev Lett 104:108101

Showing the most recent 10 out of 14 publications